Krystal Biotech Derivative Contract Liabilities (Quarterly) Analysis

Krystal Biotech, Inc. (KRYS)

272.19 +5.29 (+1.98%) USD | NASDAQ | Feb 25, 16:00

272.19 0.00 (0.00%) After-Hours: 18:30

View Derivative Contract Liabilities (Quarterly) for KRYS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Derivative Contract Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Derivative Contract Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Derivative Contract Liabilities (Quarterly) Benchmarks

Start Trial

Amicus Therapeutics, Inc.	--
DexCom, Inc.	--
Alkermes Plc	--
Regeneron Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	Upgrade